High effectiveness of platinum(IV) complex with adamantylamine in overcoming resistance to cisplatin and suppressing proliferation of ovarian cancer cells in vitro

This publication has 18 references indexed in Scilit:

• New platinum(IV) complex with adamantylamine ligand as a promising anti-cancer drug: comparison of in vitro cytotoxic potential towards A2780/cisR cisplatin-resistant cell line within homologous series of platinum(IV) complexes
  Anti-Cancer Drugs, 2004
• Platinum(IV) Complex with Adamantylamine as Nonleaving Amine Group: Synthesis, Characterization, and in Vitro Antitumor Activity against a Panel of Cisplatin-Resistant Cancer Cell Lines
  Journal of Medicinal Chemistry, 2003
• Cell Cycle and Apoptosis
  Neoplasia, 2000
• Synthesis, characterization and DNA modification induced by a novel Pt(IV)-bis(monoglutarate) complex which induces apoptosis in glioma cells
  Chemico-Biological Interactions, 1999
• Cytometry in cell necrobiology: Analysis of apoptosis and accidental cell death (necrosis)
  Cytometry, 1997
• Apoptotic and non-apoptotic cell death induced by cis and trans analogues of a novel ammine(cyclohexylamine)dihydroxodichloroplatinum(IV) complex
  British Journal of Cancer, 1996
• Carboxylation of Kinetically Inert Platinum(IV) Hydroxy Complexes. An Entr.acte.ee into Orally Active Platinum(IV) Antitumor Agents
  Inorganic Chemistry, 1995
• The Protein Kinase C Inhibitor Ilmofosine (BM 41 440) Arrests Cells in G2 Phase and Suppresses CDC2 Kinase Activation Through a Mechanism Different from That of DNA Damaging Agents
  Biochemical and Biophysical Research Communications, 1994
• New Cisplatin Analogues in Development
  Drugs, 1993
• An immunochemical analysis of the human nuclear phosphoprotein p53
  Journal of Immunological Methods, 1992